CN104757673A - Application of multipolar micro kinetic energy drinking water in preparation of beverage, health product or medicine for lowering blood pressure - Google Patents
Application of multipolar micro kinetic energy drinking water in preparation of beverage, health product or medicine for lowering blood pressure Download PDFInfo
- Publication number
- CN104757673A CN104757673A CN201510125016.XA CN201510125016A CN104757673A CN 104757673 A CN104757673 A CN 104757673A CN 201510125016 A CN201510125016 A CN 201510125016A CN 104757673 A CN104757673 A CN 104757673A
- Authority
- CN
- China
- Prior art keywords
- water
- frequency electromagnetic
- drinking water
- wave
- electromagnetic wave
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000020188 drinking water Nutrition 0.000 title claims abstract description 119
- 239000003651 drinking water Substances 0.000 title claims abstract description 119
- 239000003814 drug Substances 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 235000013361 beverage Nutrition 0.000 title claims abstract description 8
- 230000036541 health Effects 0.000 title claims abstract description 8
- 230000036772 blood pressure Effects 0.000 title abstract description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 150
- 238000000034 method Methods 0.000 claims abstract description 75
- 230000008569 process Effects 0.000 claims abstract description 50
- 238000010521 absorption reaction Methods 0.000 claims abstract description 7
- 230000033001 locomotion Effects 0.000 claims description 77
- 230000005405 multipole Effects 0.000 claims description 65
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 24
- 239000011707 mineral Substances 0.000 claims description 24
- 235000020682 bottled natural mineral water Nutrition 0.000 claims description 17
- 208000001953 Hypotension Diseases 0.000 claims description 8
- 208000021822 hypotensive Diseases 0.000 claims description 8
- 230000001077 hypotensive effect Effects 0.000 claims description 8
- 239000008399 tap water Substances 0.000 claims description 3
- 235000020679 tap water Nutrition 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 239000000654 additive Substances 0.000 abstract description 2
- 230000000996 additive effect Effects 0.000 abstract description 2
- 230000005855 radiation Effects 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 description 75
- 238000012360 testing method Methods 0.000 description 48
- 241000700159 Rattus Species 0.000 description 47
- 238000002474 experimental method Methods 0.000 description 41
- ZPBWCRDSRKPIDG-UHFFFAOYSA-N amlodipine benzenesulfonate Chemical compound OS(=O)(=O)C1=CC=CC=C1.CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl ZPBWCRDSRKPIDG-UHFFFAOYSA-N 0.000 description 37
- 229960004005 amlodipine besylate Drugs 0.000 description 25
- 210000004027 cell Anatomy 0.000 description 19
- 230000037396 body weight Effects 0.000 description 16
- 230000035488 systolic blood pressure Effects 0.000 description 16
- 239000000463 material Substances 0.000 description 15
- 230000008859 change Effects 0.000 description 14
- 206010020772 Hypertension Diseases 0.000 description 13
- 230000003203 everyday effect Effects 0.000 description 13
- 230000002269 spontaneous effect Effects 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- 229910021642 ultra pure water Inorganic materials 0.000 description 13
- 239000012498 ultrapure water Substances 0.000 description 13
- 229960000528 amlodipine Drugs 0.000 description 12
- 230000035487 diastolic blood pressure Effects 0.000 description 11
- 239000002609 medium Substances 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 9
- 239000000835 fiber Substances 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 8
- 230000003595 spectral effect Effects 0.000 description 8
- 238000007689 inspection Methods 0.000 description 7
- 150000002978 peroxides Chemical class 0.000 description 7
- 230000001052 transient effect Effects 0.000 description 7
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000002189 fluorescence spectrum Methods 0.000 description 6
- 230000005778 DNA damage Effects 0.000 description 5
- 231100000277 DNA damage Toxicity 0.000 description 5
- 238000010171 animal model Methods 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 241000251468 Actinopterygii Species 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 241001269238 Data Species 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000001543 one-way ANOVA Methods 0.000 description 4
- -1 oxonium ion Chemical class 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 239000003643 water by type Substances 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000002929 anti-fatigue Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 239000004973 liquid crystal related substance Substances 0.000 description 3
- 230000009965 odorless effect Effects 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229940116269 uric acid Drugs 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 208000034657 Convalescence Diseases 0.000 description 2
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 2
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 206010015548 Euthanasia Diseases 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000005374 Poisoning Diseases 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 231100000460 acute oral toxicity Toxicity 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 239000006053 animal diet Substances 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000010835 comparative analysis Methods 0.000 description 2
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000000384 rearing effect Effects 0.000 description 2
- 238000006479 redox reaction Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 230000003313 weakening effect Effects 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 239000000980 acid dye Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002384 drinking water standard Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000009863 impact test Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108700028309 rat Neurog3 Proteins 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to an application of multipolar micro kinetic energy drinking water in preparation of beverage, health product or medicine for lowering blood pressure. The multipolar micro kinetic energy drinking water is prepared by drinking water raw water through electromagnetic wave non-contact preparation, compared with the drinking water raw water, an ultraviolet absorption peak is offset to a short wave direction by 25nm-40nm, preferably offset to the short wave direction by 28nm-30nm, and the most preferably offset to the short wave direction by 30nm or 28nm. The application employs an electromagnetic wave non-contact mold to process water, no additive is added, and the application has the advantages of simple operation, high production efficiency and low cost, and the prepared multipolar micro kinetic energy drinking water has more extra nuclear electron in a high energy level non-radiation energy level state.
Description
Technical field
The invention belongs to water-treatment technology field, be specifically related to multipole fine motion energy drinking water for the preparation of the purposes in hypotensive beverage, health products or medicine.
Background technology
Water (H
2o) inorganic matter be made up of hydrogen, oxygen two kinds of elements is the transparency liquid of colorless and odorless at normal temperatures and pressures.Water is one of modal material, and being the valuable source comprising all life existence of the mankind, is also the most important part of organism.Water plays an important role in Life Evolution.The mankind start to create understanding to water very early, ancient times between east and west simplicity view of matter in all water is considered as a kind of basic component.
Modern has following understanding with the angle of science to water:
Hydrone has memory: when scientist the snow crystals individually with difformity and weight dissolved respectively then freeze again time, find shape and the weight of the snow crystals again freezed and dissolve front just the same, obtaining the conclusion that water outlet itself has " memory ".
Due to the planform that hydrone itself has it special, it be by two hydrogen and oxonium ion with 104.5 angle be combined into.It is a kind of ionizing system with electronics " magnetic polarity ".Hydrone presents solid-state crystalline solid at zero degree and subzero, and we are referred to as ice.But water is not present aqueous completely at the temperature of zero to 60 DEG C, but exists with a kind of form of liquid crystal.If but temperature is higher than 60 DEG C, this liquid lens element just can wreck.
Due to the special angle mode of hydrone, the body of diluted solute molecule can be included in its liquid crystal, Here it is general understood course of dissolution.Present new discovery is, when by some means or other making solute molecule be separated with hydrone (as via dilution repeatedly and concussion), hydrone still can keep remembering " shape " of solute molecule.When body cell touches such hydrone, " shape " of this solute molecule memory can be used as genuine solute molecule and equally treat, this is the hahnemannian foundation stone having more than 200 year history.
Water is combined into by hydrogen and oxygen two kinds of elements, but is not present in nature with single hydrone, but is agglomerated into the group (H of hydrone by many hydrones
2o)
nbe present in nature (namely above-mentioned liquid crystals), the group of hydrone may be chain, ring-type, bulk or botryoidalis, minimum five hydrones, at most tens, tens of to hundreds of.
Have at present and adopted electromagnetic wave to process hydrone, with the method improving the energy grade of hydrone or sterilization or prevention and take out stains.But these processing methods all can not the effect of control treatment well, and the effect of water after process is only limitted to drink mostly, does not have other additional advantageous effects.
Summary of the invention
In order to overcome the defect of prior art, the invention provides a kind of multipole fine motion energy drinking water adopting the contactless process of electromagnetic wave to obtain and its production and use.
An object of the present invention is to provide a kind of multipole fine motion energy drinking water.Another object of the present invention is to provide a kind of preparation method of above-mentioned multipole fine motion energy drinking water.Another object of the present invention is to provide a kind of purposes of above-mentioned multipole fine motion energy drinking water.
Above-mentioned purpose of the present invention adopts following technical scheme to realize.
On the one hand, the invention provides a kind of multipole fine motion energy drinking water, this multipole fine motion energy drinking water is prepared from by the contactless process of electromagnetic wave by Raw Drinking Water, compared with Raw Drinking Water, ultraviolet absorption peak is to shortwave direction skew 25nm-40nm, preferably to shortwave direction skew 28nm-30nm, most preferably to shortwave direction skew 30nm or 28nm.
Compared with Raw Drinking Water, the fluorescence emission spectrum intensity of multipole fine motion energy drinking water of the present invention all has at 300nm-400nm spectral coverage and significantly promotes, and repeat experiment to sample of the same race and show, this experiment has good repeatability.
Experiment shows, multipole fine motion energy drinking water of the present invention has more electron outside nucleus and is in the non-radiative energy level state of high level.
Preferably, described Raw Drinking Water is ordinary tap water or various mineral water or pure water, such as Evian natural mineral water, Glacier in Tibet mineral water, NongFuShanQuan, Wahaha etc.
Multipole fine motion energy drinking water of the present invention is drunk in 72 hours or result of use the best after preparing.
On the other hand, the invention provides a kind of preparation method of above-mentioned multipole fine motion energy drinking water, this preparation method comprises the former water of the contactless Drinking Water of electromagnetic wave adopting basic, normal, high three kinds of different frequencies, wherein, the frequency range of low-frequency electromagnetic wave is 30-100kHz, intermediate frequency electromagnetic wave frequency scope is 550-720kHz, and the frequency range of frequency electromagnetic waves is 300-725MHz.
Preferably, described Raw Drinking Water is ordinary tap water or various mineral water or pure water, such as Evian natural mineral water, Glacier in Tibet mineral water, NongFuShanQuan, Wahaha etc.
Preferably, the frequency range of described low-frequency electromagnetic wave is 45-75kHz.
Preferably, described intermediate frequency electromagnetic wave frequency scope is 600-720kHz.
Preferably, the frequency range of described frequency electromagnetic waves is 300-425MHz.
Preferably, described low-frequency electromagnetic wave and medium frequency electric magnetic wave are sine wave, square wave, sharp wave, sawtooth waveforms or trapezoidal wave.
Preferably, described low-frequency electromagnetic wave can be identical or different with intermediate frequency electromagnetic waveform, preferably identical.
Preferably, described low-frequency electromagnetic wave is consistent with intermediate frequency electromagnetic direction of wave travel.
Preferably, described frequency electromagnetic waves is triangular wave, and vertical with intermediate frequency electromagnetic direction of wave travel with described low-frequency electromagnetic wave.
Preferably, when adopting the contactless Drinking Water original sub-block of the electromagnetic wave of basic, normal, high three kinds of different frequencies, first use low-frequency electromagnetic wave and frequency electromagnetic waves to process simultaneously, and then use medium frequency electric magnetic wave and frequency electromagnetic waves to process simultaneously.
Preferably, the time using low-frequency electromagnetic wave and frequency electromagnetic waves simultaneously to process is 10-30 minute, is preferably 10-20 minute; The time using medium frequency electric magnetic wave and frequency electromagnetic waves simultaneously to process is 10-30 minute, is preferably 10-20 minute.
Preferably, compared with Raw Drinking Water, the ultraviolet absorption peak of the multipole fine motion energy drinking water prepared, to shortwave direction skew 25nm-40nm, preferably to shortwave direction skew 28nm-30nm, most preferably offsets 30nm or 28nm to shortwave direction.
Compared with Raw Drinking Water, the fluorescence emission spectrum intensity of multipole fine motion energy drinking water of the present invention all has at 300nm-400nm spectral coverage and significantly promotes, and repeat experiment to sample of the same race and show, this experiment has good repeatability.
Experiment shows, multipole fine motion energy drinking water of the present invention has more electron outside nucleus and is in the non-radiative energy level state of high level.
In the present invention, the method generated electromagnetic waves and device are ordinary skill in the art means.
Another aspect, the invention provides the purposes of above-mentioned multipole fine motion energy drinking water in preparation various mineral water, pure water, beverage, health products or medicine.
Preferably, described beverage is drinks, may be used for antifatigue, fat-reducing, defaecation, hypotensive, hypoglycemic, blood uric acid and plasma wrea fall.
Preferably, described health products or medicine may be used for antifatigue, fat-reducing, defaecation, hypotensive, hypoglycemic, fall blood uric acid and fall plasma wrea.
Compared with prior art, the present invention adopts the contactless process water of electromagnetic wave, does not add any additive, and make simple, production efficiency is high, and cost is low.
Compared with existing report, multipole fine motion energy drinking water of the present invention Raw Drinking Water more before treatment creates obvious displacement at ultraviolet absorption peak to shortwave direction, fluorescence emission spectrum intensity all has at 300nm-400nm spectral coverage and significantly promotes, and more electron outside nucleus is in the non-radiative energy level state of high level.Zoopery is verified have antifatigue, fat-reducing, defaecation, hypotensive, hypoglycemic, fall blood uric acid and fall plasma wrea effect.
Accompanying drawing explanation
Below, describe embodiment of the present invention in detail by reference to the accompanying drawings, wherein:
Fig. 1 is the water of different disposal group causes DNA damage impact on peroxide;
Fig. 2 is the impact of culture medium on cell of different disposal;
Fig. 3 is the absorption spectrum distribution of the multipole fine motion energy water of the present invention that the former water of common drinking water and the former water of this common drinking water of use obtain;
Fig. 4 is the absorption spectrum distribution of the multipole fine motion energy water of the present invention that Evian natural mineral water (former water) and this Evian natural mineral water of use obtain;
Fig. 5 is the absorption spectrum distribution of the multipole fine motion energy water of the present invention that Glacier in Tibet mineral water (former water) and this Glacier in Tibet mineral water of use obtain;
Fig. 6 is the fluorescence stable state transient test result of the multipole fine motion energy drinking water that common drinking water (former water) is made with it;
The fluorescence stable state transient test result of multipole fine motion energy drinking water that Fig. 7 is Evian natural mineral water (former water) and makes with it;
The fluorescence stable state transient test result of multipole fine motion energy drinking water that Fig. 8 is Glacier in Tibet mineral water (former water) and makes with it;
To be Glacier in Tibet mineral water be Fig. 9 that multipole fine motion energy drinking water that former water is made gets three samples respectively carries out reperformance test result;
Figure 10 is that multipole fine motion energy drinking water of the present invention is on the impact of SHR spontaneous hypertension rat blood pressure systolic pressure (SBP);
Figure 11 is that multipole fine motion energy drinking water of the present invention is on the impact of SHR spontaneous hypertension rat blood pressure diastolic pressure (DBP);
Figure 12 is the impact of multipole fine motion energy drinking water of the present invention on SHR spontaneous hypertension rat blood pressure average (MBP);
Figure 13 is that multipole fine motion energy drinking water of the present invention is on the impact of SHR spontaneous hypertension rat heart rate (HR);
Figure 14 is that multipole fine motion energy drinking water of the present invention is on the impact of SHR spontaneous hypertension rat body weight;
Figure 15 kinetic energy water is on the impact of normal SD rat blood pressure systolic pressure (SBP);
Figure 16 kinetic energy water is on the impact of normal SD rat blood pressure diastolic pressure (DBP);
Figure 17 kinetic energy water is on the impact of normal SD rat blood pressure mean pressure (MBP);
Figure 18 kinetic energy water is on the impact of normal SD rat heart rate;
Figure 19 kinetic energy water is on the impact test changes of weight of normal rat blood pressure.
Detailed description of the invention
Below in conjunction with detailed description of the invention, the present invention is further described in detail, the embodiment provided only in order to illustrate the present invention, instead of in order to limit the scope of the invention.
Experimental technique in following embodiment, if no special instructions, is conventional method.Medicinal raw material used in following embodiment, reagent material etc., if no special instructions, be commercially available purchase product.
the preparation method of embodiment 1 multipole fine motion of the present invention energy drinking water
Outside common drinking water raw water tubes, the electromagnetic wave of the basic, normal, high three kinds of different frequencies of contactless applying processes, and wherein, low frequency electromagnetic wave frequency is 30kHz, intermediate frequency electromagnetic wave frequency scope is 550kHz, and the frequency range of frequency electromagnetic waves is 300MHz.
Wherein, described low-frequency electromagnetic wave and medium frequency electric magnetic wave are sine wave, and the two Electromagnetic Wave Propagation direction is consistent.Described frequency electromagnetic waves is triangular wave, and vertical with intermediate frequency electromagnetic direction of wave travel with described low-frequency electromagnetic wave.During process, first use low-frequency electromagnetic wave and frequency electromagnetic waves to process 20 minutes simultaneously, and then use medium frequency electric magnetic wave and frequency electromagnetic waves to process 20 minutes simultaneously.After having processed, obtain multipole fine motion energy drinking water of the present invention.
the preparation method of embodiment 2 multipole fine motion of the present invention energy drinking water
Outside common drinking water raw water tubes, the electromagnetic wave of the basic, normal, high three kinds of different frequencies of contactless applying processes, and wherein, low frequency electromagnetic wave frequency is 100kHz, intermediate frequency electromagnetic wave frequency scope is 720kHz, and the frequency range of frequency electromagnetic waves is 725MHz.
Wherein, described low-frequency electromagnetic wave and medium frequency electric magnetic wave are square wave, and the two Electromagnetic Wave Propagation direction is consistent.Described frequency electromagnetic waves is triangular wave, and vertical with intermediate frequency electromagnetic direction of wave travel with described low-frequency electromagnetic wave.During process, first use low-frequency electromagnetic wave and frequency electromagnetic waves to process 10 minutes simultaneously, and then use medium frequency electric magnetic wave and frequency electromagnetic waves to process 10 minutes simultaneously.After having processed, obtain multipole fine motion energy drinking water of the present invention.
the preparation method of embodiment 3 multipole fine motion of the present invention energy drinking water
Outside common drinking water raw water tubes, the electromagnetic wave of the basic, normal, high three kinds of different frequencies of contactless applying processes, and wherein, low frequency electromagnetic wave frequency is 45kHz, intermediate frequency electromagnetic wave frequency scope is 600kHz, and the frequency range of frequency electromagnetic waves is 300MHz.
Wherein, described low-frequency electromagnetic wave and medium frequency electric magnetic wave are square wave, and the two Electromagnetic Wave Propagation direction is consistent.Described frequency electromagnetic waves is triangular wave, and vertical with intermediate frequency electromagnetic direction of wave travel with described low-frequency electromagnetic wave.During process, first use low-frequency electromagnetic wave and frequency electromagnetic waves to process 15 minutes simultaneously, and then use medium frequency electric magnetic wave and frequency electromagnetic waves to process 15 minutes simultaneously.After having processed, obtain multipole fine motion energy drinking water of the present invention.
the preparation method of embodiment 4 multipole fine motion of the present invention energy drinking water
Outside common drinking water raw water tubes, the electromagnetic wave of the basic, normal, high three kinds of different frequencies of contactless applying processes, and wherein, low frequency electromagnetic wave frequency is 75kHz, intermediate frequency electromagnetic wave frequency scope is 720kHz, and the frequency range of frequency electromagnetic waves is 425MHz.
Wherein, described low-frequency electromagnetic wave and medium frequency electric magnetic wave are sharp wave, and the two Electromagnetic Wave Propagation direction is consistent.Described frequency electromagnetic waves is triangular wave, and vertical with intermediate frequency electromagnetic direction of wave travel with described low-frequency electromagnetic wave.During process, first use low-frequency electromagnetic wave and frequency electromagnetic waves to process 20 minutes simultaneously, and then use medium frequency electric magnetic wave and frequency electromagnetic waves to process 20 minutes simultaneously.After having processed, obtain multipole fine motion energy drinking water of the present invention.
the physical and chemical index of embodiment 5 multipole fine motion of the present invention energy drinking water detects
Detect multipole fine motion energy drinking water prepared by embodiment 1-4 according to " the drinking water standard method of inspection " (GB/T 5750-2006), testing result is basically identical, the results are shown in Table shown in 1.
The physical and chemical index testing result of table 1 multipole fine motion of the present invention energy drinking water
According to upper table, the index of fine motion energy drinking water of the present invention all meets the requirement of " standards for drinking water quality " (GB5749-2006).
the toxicological experiment of embodiment 6 multipole fine motion of the present invention energy drinking water
One, acute oral toxicity test
1, materials and methods
1.1 tested materials: fine motion energy drinking water 1.2 animal prepared by embodiment 3: provide Kun Ming mice (quality certification number: SCXK (capital) 2009-0017) by Laboratory Animal Resource research institute of National Institute for Food and Drugs Control, SPF level, body weight 18.0 ~ 22.0g, before test, animal overnight fasting, freely drinks water.
1.3 dosage groupings: tested material sets dosage as 20000mg/kg body weight, each 10 of female, buck.Cage group feeding is divided by sex.Adopt a per os gavage mode, calculate contamination amount by 0.1ml/10g body weight.
1.4 observation index: after contamination, observe the general status of animal, poisoning sign and death condition, observe two weeks time limits.During off-test, all animals are dissected, and the general pathology of record animal changes.Acute toxicity classification is carried out according to acute toxicity grading criteria.
2, result of the test
Tested material is to chmice acute Oral toxicity result of the test
3, conclusion
After contamination, animal occurs without any poisoning symptom and death condition, and have no any general pathology and change, the weight of animals is increase trend.Therefore, this tested material is to female, male small white mouse per os LD
50all be greater than 10000mg/kg body weight, belong to actual nontoxic level.
Two, DNA damage impact is caused on peroxide
1, experiment material and equipment
1.1 5mM vitamin c solutions: be dissolved in tri-distilled water, existingly now join, and vitamin C powder is provided by Sigma-Aldrich company;
1.2 5mM CuCl
2solution: be dissolved in tri-distilled water, matching while using, CuCl
2powder is provided by Chemical Reagent Co., Ltd., Sinopharm Group;
1.3 DNAs: pET28a plasmid increases extraction (plasmid extraction kit is purchased from Promega company) in DH5a Escherichia coli;
1.4 5mMEDTA pH value of solution 8.0:EDTA are provided by Chemical Reagent Co., Ltd., Sinopharm Group;
1.5 10 × PBS buffer solution: 80gNaCl, 2gKCl, 14.4gNa
2hPO
4, 2.4gKH
2pO
4be dissolved in distilled water, adjust pH to 7.4 is also settled to 1L autoclaving, and required reagent is all purchased from Chemical Reagent Co., Ltd., Sinopharm Group;
1.6 agaroses: provided by Biowest company;
1.7 Goldview nucleic acid dyes are provided by Biotium company;
1.8 cohesion imagers: Science and Technology Ltd. provides by the foundation of match intelligence;
1.9 electrophoresis apparatuses: 61 instrument plants;
1.10 tested materials: fine motion energy drinking water prepared by embodiment 3 and 4
2, experimental technique
2.1 experiment groupings
I group: untreated fish group, adopts untreated sterilized water to add reaction system;
II group: fine motion energy drinking water prepared by embodiment 3;
III group: fine motion energy drinking water prepared by embodiment 4.
Add each reactive material according to following order, reaction system final volume is 10 μ L:
10 × PBS buffer solution 1 μ L;
DNA (2 μ g) 2 μ L;
5mM vitamin C 1 μ L;
5mM CuC1
21μL；
With untreated water or process water polishing to 10 μ L.
2.2, respectively at 0.5 hour and l hour, add l μ L 5mM EDTA and 2.2 μ L sample-loading buffer cessation reactions;
2.3 0.8% agar chaff gel (containing Goldview dyestuff) electrophoresis l h;
2.4 gel imaging.
3, experimental result
Vitamin C and bivalent cupric ion generation redox reaction, along with the generation of peroxide, peroxide can cause Damage and Fracture to DNA, is embodied in weakening of electrophoretic band.As shown in Figure 1, experiment is divided into 3 groups to this experimental result, describes, every group reaction two time points: 0.5 hour and 1 hour, the brightness representation DNA content of DNA in the square case of group technology.Experimentally result display, II group, III group are compared with untreated I group, and the speed of DNA oxidated reduction reaction degraded is basically identical, does not produce the effect stoping or accelerate DNA damage fracture because of the process of water.
4, interpretation of result
Vitamin C and bivalent cupric ion generation redox reaction, along with the generation of peroxide, peroxide can cause Damage and Fracture to DNA, is embodied in weakening of electrophoretic band.This experimental result shows, and II group, III group are compared with untreated I group, and the speed of DNA oxidated reduction reaction degraded is basically identical, and because of the process of water, industry does not stop or accelerates the effect of DNA damage fracture.Illustrate that multipole fine motion energy water of the present invention causes DNA damage without impact to peroxide.
Three, in vitro culture HepG2 cell membrane integrity is affected
1, experiment material and equipment
L.1 human liver cancer cell: HepG2;
1.2 cell culture mediums: DMEM nutrient solution+10%FBS;
1.3 FAM-aptamer: purchased from Shanghai Sheng Gong bioengineering Co., Ltd;
1.4 fluorescence EZ micro mirrors: OLYMPUS company;
1.5 96 porocyte culture plates;
2, experimental technique
2.1 by the cell of exponential phase, adds appropriate trypsinization.Adjustment cell concentration, is inoculated in 96 well culture plates with the amount of 4000 cells/well, incubated overnight;
The 2.2 method process 40 minutes (processed group) 5mL being adopted embodiment 3 containing the DMEM culture medium (culture medium A) of 10%FBS;
2.3 by 5mL containing the DMEM culture medium (all support base B) of 10%FBS away from electromagnetic wave source more than 2 meters process 40 minutes (untreated fish group) of embodiment 3;
The C6-8aptamer that 4 μ g FAM mark joins in 100 μ L culture medium A and culture medium B and mixes by 2.4 respectively;
The cell liquid of adhere-wall culture in 96 orifice plates to be replaced by culture medium A containing FAM-C6-8 aptamer and culture medium B by 2.5,37 DEG C cultivate 30min after, wash once with PBS, fluorescence microscopy Microscopic observation.
3, experimental result
Result is as Fig. 2, and what difference is the cellular morphology in processed group and untreated fish group do not have, and be all cell white hair fluorescence, cell membrane is complete, does not observe the C6-8aptamer green fluorescence that obvious FAM marks in cell.
4, results and analysis
If cell exist punch; FAM mark C6-8aptamer can enter cell and with intracellular protein combination, fluoresced green after 530 wavelength excite.And result sees what difference the cell in processed group and untreated fish group does not have in figure, be all cell autofluorescence, illustrate that cell membrane is complete, multipole fine motion energy technology of the present invention on cellular morphology and cell membrane integrity without impact.
wide spectral absorptivity and the rate of absorbing UV of embodiment 7 multipole fine motion of the present invention energy drinking water become
change
1, experiment material and equipment
Fine motion energy drinking water prepared by 1.1 embodiments 3;
The former water of common drinking water used in 1.2 embodiments 3;
1.3 drinking water adopting the identical method process Evian natural mineral water of embodiment 3 to make;
1.4 Evian natural mineral waters: buy in Carrefour hypermarket;
1.5 drinking water adopting the identical method process Glacier in Tibet mineral water of embodiment 3 to make;
1.6 Glacier in Tibet mineral waters: buy in Carrefour hypermarket;
1.7 ultra-pure waters: obtained by German Sartorius ultrapure water production system;
1.8 fiber spectrometer Ava-Spec3648, measurement category 200-1100nm, uncertainty/degree of accuracy 0.5nm;
1.9 oscillograph MS04104, equipment factory number: C001163, certainty of measurement: 1GHz;
1.10 photodetector Thorlab DET10A/M, equipment factory number: JGZX-ZXZC-012, certainty of measurement: 200nm-1100nm;
1.11 test conditions: temperature 21 DEG C, humidity: 38%.
2, experimental technique
The absorptivity of 2.1 wide spectral
(1) about 200ml ultrapure water experiment vessel are used to stablize to every physical and chemical index.
(2) fine motion energy drinking water prepared by the former water of common drinking water used in embodiment 3 and embodiment 3 is placed in experimental ware, the absorption of scanning 200nm ~ 800nm sample standard light source light spectrum light splitting, record experimental result.
(3) about 200ml ultrapure water experiment vessel to every physical and chemical index is used to recover initial value and stablize.
(4) Evian natural mineral water is placed in experimental ware with the drinking water adopting the identical method process Evian natural mineral water of embodiment 3 to make, repeats step (2), uitraviolet intensity variable quantity during record.
(5) about 200ml ultrapure water experiment vessel to every physical and chemical index is used to recover initial value and stablize.
(6) Glacier in Tibet mineral water is placed in experimental ware with the drinking water adopting the identical method process Glacier in Tibet mineral water of embodiment 3 to make, repeats step (2), uitraviolet intensity variable quantity during record.
(7) about 200ml ultrapure water experiment vessel to every physical and chemical index is used to recover initial value and stablize.
2.2 rate of absorbing UVs measure
(1) about 200ml ultrapure water experiment vessel are used to stablize to every physical and chemical index.
(2) fine motion energy drinking water embodiment 3 prepared is placed in uitraviolet intensity detection system, ultraviolet source irradiation water to be measured, the uitraviolet intensity numerical value of photodetector ThorlabDET10A/M reading without water to be measured is read by oscillograph MS04104, read the uitraviolet intensity numerical value through water to be measured, uninterrupted test 72 hours continuously, uitraviolet intensity variable quantity during record.
(3) about 200ml ultrapure water experiment vessel to every physical and chemical index is used to recover initial value and stablize.
(4) drinking water adopting the identical method process Evian natural mineral water of embodiment 3 to make is placed in uitraviolet intensity detection system, repeats step (2), uitraviolet intensity variable quantity during record.
(5) about 200ml ultrapure water experiment vessel to every physical and chemical index is used to recover initial value and stablize.
(6) drinking water adopting the identical method process Glacier in Tibet mineral water of embodiment 3 to make is placed in uitraviolet intensity detection system, repeats step (2), uitraviolet intensity variable quantity during record.
(7) about 200ml ultrapure water experiment vessel to every physical and chemical index is used to recover initial value and stablize.
3, experimental result
3.1 wide spectral absorption rate testings
The results are shown in Figure 3-5.
3.2 rate of absorbing UVs measure
The multipole fine motion energy drinking water that light water is made:
Rate of absorbing UV: 0.9135->0.9037
The multipole fine motion energy drinking water that Evian natural mineral water is made:
Rate of absorbing UV: 0.9244->0.9188
The multipole fine motion energy drinking water that Glacier in Tibet mineral water is made:
Rate of absorbing UV: 0.9157->0.9079
4, experiment conclusion and analysis
By above-mentioned experiment, obtain as drawn a conclusion:
(1) compare with former aqueous phase, the absorption spectrum absworption peak of multipole fine motion energy drinking water of the present invention is to shortwave skew about 30nm;
(2) under the test of 72 hours, the absorptivity of multipole fine motion energy drinking water of the present invention declines 1%.
the excited fluorescence spectrum change of embodiment 8 multipole fine motion of the present invention energy drinking water
1, experiment material and equipment
Fine motion energy drinking water prepared by 1.1 embodiments 3;
The former water of common drinking water used in 1.2 embodiments 3;
1.3 drinking water adopting the identical method process Evian natural mineral water of embodiment 3 to make;
1.4 Evian natural mineral waters: buy in Carrefour hypermarket;
1.5 drinking water adopting the identical method process Glacier in Tibet mineral water of embodiment 3 to make;
1.6 Glacier in Tibet mineral waters: buy in Carrefour hypermarket;
1.7 ultra-pure waters: obtained by German Sartorius ultrapure water production system;
1.8 fiber spectrometer Ava-Spec3648, measurement category 200-1100nm, uncertainty/degree of accuracy 0.5nm;
1.9 test environments: temperature 22 DEG C, humidity 37%.
2, experimental technique
(1) about 200mL ultrapure water experiment vessel are used to stablize to every physical and chemical index.
(2) fine motion energy drinking water embodiment 3 prepared is placed in fiber spectrometer sample cell, with 266nm pulsed ultraviolet laser to sample excitation pulse, use fiber spectrometer spectral scan function, to measure the emission spectrum of sample, the fluorescence emission spectrum of record sample.
(3) about 200mL ultrapure water experiment vessel to every physical and chemical index is used to recover initial value and stablize.
(4) the former water of common drinking water used in embodiment 3 is placed in fiber spectrometer sample cell, repeats step 2, record experimental data.
(5) about 200mL ultrapure water experiment vessel to every physical and chemical index is used to recover initial value and stablize.
(6) drinking water adopting the identical method process Evian natural mineral water of embodiment 3 to make is placed in optical spectrometer sample pond, repeats step 2,3, record experimental data.
(7) Evian natural mineral water is being placed in fiber spectrometer sample cell, is repeating step 2,3 record experimental datas.
(8) drinking water adopting the identical method process Glacier in Tibet mineral water of embodiment 3 to make is put in fiber spectrometer sample cell, repeat step 2,3 record experimental datas.
(9) Glacier in Tibet mineral water is placed in fiber spectrometer sample cell, repeats step 2,3 record experimental datas.
(10) drinking water adopting the identical method process Glacier in Tibet mineral water of embodiment 3 to make is got three samples and be placed in fiber spectrometer sample cell respectively, repeat step 2,3 record experimental datas.
3, experimental result
3.1 fluorescence stable state transient tests
The fluorescence stable state transient test of the multipole fine motion energy drinking water that common drinking water is made with it the results are shown in Figure 6.Evian natural mineral water and the fluorescence stable state transient test of multipole fine motion energy drinking water made with it the results are shown in Figure 7.Glacier in Tibet mineral water and the fluorescence stable state transient test of multipole fine motion energy drinking water made with it the results are shown in Figure 8.Glacier in Tibet mineral water is that multipole fine motion energy drinking water that former water is made is got three samples respectively and carried out reperformance test, the results are shown in Figure 9.
4, experiment conclusion and analysis
As can be seen from above-mentioned experimental result, compare with former aqueous phase, the fluorescence emission spectrum intensity of three kinds of different samples of multipole fine motion energy drinking water of the present invention all has at 300nm-400nm spectral coverage and significantly promotes, and repeat experiment to sample of the same race and show, this experiment has good repeatability.
Experiment shows, multipole fine motion energy water drinking water of the present invention has more electron outside nucleus and is in the non-radiative energy level state of high level.
embodiment 9 multipole fine motion of the present invention energy drinking water is to SHR spontaneous hypertension rat blood pressure
impact
1. materials and methods
1.1 samples:
Multipole fine motion energy drinking water (kinetic energy water) prepared by embodiment 3, the transparent aqueous liquid of colorless and odorless, normal temperature is preserved, and prepares in rear 72h and uses;
Positive drug Amlodipine Besylate Tablet, is produced by Guangdong Bidi Pharmaceutical Co., Ltd, lot number 20140401.
1.2 animals used as test: SHR rat, purchased from Beijing Bioisystech Co., Ltd of dimension tonneau China, production licence number: SCXK (capital) 2012-0001, the Quality of Experimental Animals quality certification number: 11400700052484.100, female, 56-69 age in days during order, selects 50 rats to be used for formal test after screening.
Rearing conditions: Laboratory Animal Facility continues to keep barrier environment standard.The control range of main environment index: room temperature 20 ~ 26 DEG C, temperature difference per day≤4 DEG C.Relative humidity 40 ~ 70%.Minimum air changes 15 times/hour, optical illumination: dark=12h:12h.Animal feeding is in polypropylene rat group support box, and cage tool specification is: 545*395*200mm
3, 5, every box, its cultured space meets the regulation about minimum space needed for animal used as test in National Standard of the People's Republic of China GB14925-2010.All animals carry out feeding and management by the qualified personnel of training.Change 1 bedding and padding and cage tool weekly.Add mouse special feed every day for animal edible, in whole feeding process, keep animal diet followed freedom of movement.
Animal welfare: this tests animal used and the requirement disposed and should meet animal welfare of being correlated with, and experiment is carried out will through the examination and approval of the Chinese Academy of Medical Sciences Beijing Union Medical College new drug Research on Safety Assessment central animals management and committee (IACUC).Concrete points for attention are as follows:
(1), in experimentation, the terrified of animal and pain should be reduced to a minimum.
(2) performing the operation to animal used as test, when dissected, must effectively anaesthetize.The convalescence after Miles operation according to actual conditions, should carry out analgesia and nurses targetedly and dietetic regulation.
(3), during the animal used as test of Baoding, should avoid causing the uneasiness of animal, terrified, pain and damage.Restraint appliance should rational in infrastructure, specification suitable, sturdy and durable, environmentally-friendly sanitary, convenient operation.Under the prerequisite not affecting experiment, should be reduced to a minimum to the mandatory restriction of animal bodies.
(4) sample collection: the operation in the mode of safety humanity (as far as possible reduce cause animal anxiety with uncomfortable), animal used as test being carried out to collecting sample.
(5) for the animal that moribund animals, infected animal and toxic reaction are serious, notify at once to animal doctor and thematic director, give treatment in time or implement euthanasia.When not affecting experimental result and judging, select " kind terminal ", avoid extending animal and bear the painful time.When putting to death animal used as test, implement mercy killing according to principle of humanitarianism.Put to death on-the-spot, on the scene without other animals.After confirming animal dead, properly dispose corpse.
(6) employment security aspect: in experimentation, notes taking personal protective measures, as gloves, barrier gown, face shield, eyeshade, earplug etc.
1.4 key instruments and reagent: BP-98A intelligence non-invasive blood pressure measuring.
1.5 test methods:
1.5.1 the standard followed: the auxiliary function for lowering blood pressure method of inspection, health food inspection and assessment technical specification (2003 editions); State's food medicine prison No. [2012] 107, guarantorization.
1.5.2 Testing index: the observation of animal ordinary circumstance, body weight, upgrowth situation, blood pressure, heart rate.
1.5.3 animal grouping and dose design: adapt to quarantine 2 weeks after animal receives, choose 50 animals at the end of quarantine and carry out random layering grouping according to blood pressure determination result, be divided into 5 groups, often organize 10.Blank group drinks normal drinking water every day; Kinetic energy water low dose group drinks kinetic energy water (the filling kinetic energy water of drinking bottle, daily iron supplement 1 time) every day; Kinetic energy water high dose group except kinetic energy water is drunk on basis every day, every day gavage kinetic energy water once, dosage is 1.5mL/100g; Positive drug Amlodipine Besylate Tablet group gavage every day once, dosage is 2mg/kg, administration volume is that 1.5mL/kg (be grown up every consumption per day 10mg by Amlodipine Besylate Tablet, body weight for humans calculates according to 60kg, for 0.167mg/kg, 2mg/kg is about 12 times of people's dosage, prepares with 0.5%CMC-Na); It is also 2mg/kg that kinetic energy water adds Amlodipine Besylate Tablet group Amlodipine Besylate Tablet dosage, prepares with kinetic energy water.
Table 2 kinetic energy water affects dose design to SHR spontaneous hypertension rat blood pressure
1.5.4 administration time: successive administration 40 days.
1.5.5 minute:
Before grouping, administration the 15th day, administration the 36th day, to stop after administration 2 weeks, mensuration 4 times altogether.
1.6 test data statistics:
Use SPSS statistical software process body weight result and carry out the comparative analysis of administration group and control group.Add up in accordance with the following methods: Kolmogorov-Smirnov method should be adopted to carry out Normal distribution test, Levene median method carries out homogeneity test of variance, if P > 0.05, carry out one-way analysis of variance (One-Way ANOVA) method, if normal state and homogeneity test of variance failure (P≤0.05), so need to carry out nonparametric Mann-Whitney inspection.
1.7 results judge:
Result judges: Amlodipine Besylate Tablet treated animal blood pressure is starkly lower than blank group, and difference has conspicuousness, shows the success of SHR rat model; If kinetic energy water treated animal blood pressure is starkly lower than blank group, difference has conspicuousness, on animal heart rate without impact, can judge that kinetic energy glassware for drinking water has auxiliary function for lowering blood pressure; If kinetic energy water group Amlodipine Besylate Tablet group blood pressure reduces lower than Amlodipine Besylate Tablet group, then can judge that kinetic energy glassware for drinking water has the effect strengthening Amlodipine Besylate Tablet blood pressure lowering effect.
2. result:
Animal ordinary circumstance is observed each group and is showed no exception.
Table 3 kinetic energy water on the impact of SHR spontaneous hypertension rat blood pressure systolic pressure (SBP) (mmHg,
n=10)
Note: * *, and compares, p<0.01
From table 3, Figure 10, before medicine, each group rat systolic pressure (SBP) result is comparatively consistent, is showed no significant difference.
Successive administration 15 days, compare with control group, kinetic energy water is low, high dose group, Amlodipine 2mg/kg group, Amlodipine Besylate Tablet 2mg/kg add the decrease to some degree of kinetic energy water group each group systolic pressure value, but amplitude of variation is little, has no significant difference (p>0.05).
Successive administration 36 days, compare with control group, kinetic energy water is low, high dose group, Amlodipine 2mg/kg group, Amlodipine Besylate Tablet 2mg/kg add kinetic energy water group rat systolic pressure and all obviously reduce (188 ± 18**, 193 ± 10**, 156 ± 19**, 155 ± 12**, vs 216 ± 21, mmHg, * * p<0.01), it is 13.0% that kinetic energy water low dose group reduces amplitude, and it is 10.6% that kinetic energy water high dose group reduces amplitude.
Recover 2 weeks after drug withdrawal, compare with control group, kinetic energy water is low, the systolic pressure of high dose group returns to control group level, have no significant difference; Amlodipine 2mg/kg group, Amlodipine Besylate Tablet 2mg/kg add kinetic energy water group systolic pressure and also return to control group level.
Table 4 kinetic energy water on the impact of SHR spontaneous hypertension rat blood pressure diastolic pressure (DBP) (mmHg,
n=10)
Note: *
,*, compares with control group, p<0.05, p<0.01
From table 4, Figure 11, before medicine, each group rat diastolic pressure (DBP) result is comparatively consistent, is showed no significant difference.
Successive administration 15 days, compare with control group, kinetic energy water is low, high dose group, Amlodipine 2mg/kg group, Amlodipine Besylate Tablet 2mg/kg add the decrease to some degree of kinetic energy water group each group diastolic pressure, but amplitude of variation is little, has no significant difference (p>0.05).
Successive administration 36 days, compare with control group, the decrease to some degree of kinetic energy water low group of rat diastolic pressure, reduction amplitude is 11.2%, but has no significant difference, and high dose group has no significant difference, Amlodipine 2mg/kg group, Amlodipine Besylate Tablet 2mg/kg group rat diastolic pressure all significantly reduce (135 ± 23,148 ± 9,111 ± 24**, 99 ± 14**, vs 152 ± 10, mmHg, * * p<0.01).
Recover 2 weeks after drug withdrawal, compare with control group, kinetic energy water is low, the diastolic pressure of high dose group returns to control group level, have no significant difference; Amlodipine 2mg/kg group, Amlodipine Besylate Tablet 2mg/kg add kinetic energy water group systolic pressure and also return to control group level.In addition Amlodipine Besylate Tablet 2mg/kg adds kinetic energy water group systolic pressure, mean pressure increases more to some extent with control group, has significant difference (systolic pressure: 154 ± 13*, vs 138 ± 14; Mean pressure: 174 ± 13*, vs 161 ± 13, mmHg, * p<0.05), infer this phenomenon and the obvious step-down of continuous use, after drug withdrawal, the bounce-back of blood pressure physiological is relevant.
Table 5 kinetic energy water on the impact of SHR spontaneous hypertension rat blood pressure mean pressure (MBP) (mmHg,
n=10)
Note: *
,*, compares with control group, p<0.05, p<0.01
From table 5, Figure 12, before medicine, each group rat mean pressure (MBP) result is comparatively consistent, is showed no significant difference.
Successive administration 15 days, compare with control group, kinetic energy water is low, high dose group, Amlodipine 2mg/kg group, Amlodipine Besylate Tablet 2mg/kg add the decrease to some degree of kinetic energy water group each group mean pressure numerical value, but amplitude of variation is little, has no significant difference (p>0.05).
Successive administration 36 days, compare with control group, the low group of rat mean pressure decrease to some degree of kinetic energy water, have significant difference, reduction amplitude is 11.0%, and high dose group has no significant change, Amlodipine 2mg/kg group, Amlodipine Besylate Tablet 2mg/kg add kinetic energy water group rat relax mean pressure all significantly reduce (153 ± 19*, 163 ± 9,126 ± 22**, 118 ± 11**, vs 172 ± 11, mmHg, * p<0.05, * * p<0.01).
Recover 2 weeks after drug withdrawal, compare with control group, kinetic energy water is low, the mean pressure of high dose group all returns to control group level, have no significant difference; Amlodipine 2mg/kg group, Amlodipine Besylate Tablet 2mg/kg add kinetic energy water group systolic pressure and also return to control group level, in addition Amlodipine Besylate Tablet 2mg/kg adds the mean pressure of kinetic energy water group increases more to some extent with control group, there is significant difference (174 ± 13*, vs 161 ± 13, mmHg, * p<0.05), infer this phenomenon and the obvious step-down of continuous use, after drug withdrawal, the bounce-back of blood pressure physiological is relevant.
Table 6 kinetic energy water on the impact of SHR spontaneous hypertension rat heart rate (secondary/min,
n=10)
Note: *
,*, compares with control group, p<0.05, p<0.01
From table 6, Figure 13, before medicine, each group rat heart rate (HR) result is comparatively consistent, is showed no significant difference.
Successive administration 15 days, compares with control group, and kinetic energy water is low, high dose group heart rate absolute value increases to some extent, but has no significant difference; Amlodipine 2mg/kg group, Amlodipine Besylate Tablet 2mg/kg add kinetic energy water group heart rate to be increased to some extent, has significant difference (454 ± 44*, 475 ± 57*, vs 359 ± 124, secondary/min, * p<0.05).
Successive administration 36 days, compares with control group, and kinetic energy water is low, high dose group, and Amlodipine 2mg/kg group, Amlodipine Besylate Tablet 2mg/kg add kinetic energy water group heart rate and have no significant difference.
Recover 2 weeks after drug withdrawal, compare with control group, kinetic energy water low dose group, Amlodipine Besylate Tablet 2mg/kg add kinetic energy water group heart rate and compare with control group and have no significant difference, kinetic energy water high dose group, Amlodipine Besylate Tablet 2mg/kg group heart rate increase to some extent, there is significant difference (438 ± 60*, 439 ± 44**, vs 361 ± 67, secondary/min, * p<0.05, * * p<0.01).
Table 7 kinetic energy water on the impact of SHR spontaneous hypertension rat body weight (g,
n=10)
From table 7, Figure 14, kinetic energy water successive administration 15 days, administration 36 days, compare with control group, kinetic energy water be low, high dose group, and it is heavy more consistent that Amlodipine 2mg/kg group, Amlodipine Besylate Tablet 2mg/kg add kinetic energy water group kinetic energy water body.
3. brief summary
Comprehensive the above results, under this experiment condition, drinks multipole fine motion energy drinking water of the present invention continuously 36 days, to a certain degree can reduce systolic pressure and the mean pressure of SHR spontaneous hypertension rat.
Prompting kinetic energy glassware for drinking water has the effect reduced blood pressure.
embodiment 10 multipole fine motion of the present invention energy drinking water is on the impact of normal SD rat blood pressure
1. materials and methods
1.1 samples:
Multipole fine motion energy drinking water (kinetic energy water) prepared by embodiment 3, the transparent aqueous liquid of colorless and odorless, normal temperature is preserved, and prepares in rear 72h and uses;
Positive drug chiang ya wan, is produced by Beijing Tongrentang Technology Development Co.ltd. Pharmaceutical Factory, lot number 12072918.
1.2 animals used as test: SD rat, purchased from Beijing HFK Bio-Technology Co., Ltd., production licence number: SCXK (capital) 2009-0004,40, male, order body weight 160 ~ 180g.The Quality of Experimental Animals quality certification number: 11401300009312.
Rearing conditions: Laboratory Animal Facility continues to keep barrier environment standard.The control range of main environment index: room temperature 20 ~ 26 DEG C, temperature difference per day≤4 DEG C.Relative humidity 40 ~ 70%.Minimum air changes 15 times/hour, optical illumination: dark=12h:12h.Animal feeding is in polypropylene rat group support box, and cage tool specification is: 545*395*200mm
3, 5, every box, its cultured space meets the regulation about minimum space needed for animal used as test in National Standard of the People's Republic of China GB14925-2010.All animals carry out feeding and management by the qualified personnel of training.Change 1 bedding and padding and cage tool weekly.Add mouse special feed every day for animal edible, in whole feeding process, keep animal diet followed freedom of movement.
Animal welfare: this tests animal used and the requirement disposed and should meet animal welfare of being correlated with, and experiment is carried out will through the examination and approval of the Chinese Academy of Medical Sciences Beijing Union Medical College new drug Research on Safety Assessment central animals management and committee (IACUC).Concrete points for attention are as follows:
(1), in experimentation, the terrified of animal and pain should be reduced to a minimum.
(2) performing the operation to animal used as test, when dissected, must effectively anaesthetize.The convalescence after Miles operation according to actual conditions, should carry out analgesia and nurses targetedly and dietetic regulation.
(3), during the animal used as test of Baoding, should avoid causing the uneasiness of animal, terrified, pain and damage.Restraint appliance should rational in infrastructure, specification suitable, sturdy and durable, environmentally-friendly sanitary, convenient operation.Under the prerequisite not affecting experiment, should be reduced to a minimum to the mandatory restriction of animal bodies.
(4) sample collection: the operation in the mode of safety humanity (as far as possible reduce cause animal anxiety with uncomfortable), animal used as test being carried out to collecting sample.
(5) for the animal that moribund animals, infected animal and toxic reaction are serious, notify at once to animal doctor and thematic director, give treatment in time or implement euthanasia.When not affecting experimental result and judging, select " kind terminal ", avoid extending animal and bear the painful time.When putting to death animal used as test, implement mercy killing according to principle of humanitarianism.Put to death on-the-spot, on the scene without other animals.After confirming animal dead, properly dispose corpse.
(6) employment security aspect: in experimentation, notes taking personal protective measures, as gloves, barrier gown, face shield, eyeshade, earplug etc.
1.4 key instruments and reagent: BP-98A intelligence non-invasive blood pressure measuring.
1.5 test methods:
1.5.1 the standard followed: the auxiliary function for lowering blood pressure method of inspection, health food inspection and assessment technical specification (2003 editions); State's food medicine prison No. [2012] 107, guarantorization.
1.5.2 Testing index: the observation of animal ordinary circumstance, body weight, upgrowth situation, blood pressure, heart rate.
1.5.3 animal grouping and dose design: adapt to quarantine 3 days after animal receives, choose 40 animals at the end of quarantine and carry out random layering grouping according to blood pressure determination result, be divided into 4 groups, often organize 10.Blank group drinks normal drinking water every day; Kinetic energy water low dose group drinks kinetic energy water (the filling kinetic energy water of drinking bottle, changes 1 every day) every day; Kinetic energy water high dose group except kinetic energy water is drunk on basis every day, every day gavage kinetic energy water once, dosage is 1.5mL/100g; Chiang ya wan group gavage every day once, dosage is 3g/kg, administration volume is that 1.5mL/100g (be grown up every consumption per day 18g by chiang ya wan, body weight for humans calculates according to 60kg, for 0.3g/kg, with 10 of people's consumption times of calculating, amount to 3g/kg, administration volume is 15mL/kg, and Pharmaceutical formulations concentration is 0.2g/mL).
Table 8 kinetic energy water is on the impact of normal animal blood pressure
1.5.4 administration time: successive administration 32 days.
1.5.5 minute:
Blood pressure determination: administration first week (administration the 4th day), administration second week (administration the 11st day), administration the 3rd week (administration the 18th day), administration 4th week (administration the 25th day)
Body weight determination: before medicine, administration first week (administration the 8th day), administration second week (administration the 15th day), administration the 3rd week (administration the 22nd day), administration 4th week (administration the 29th day)
1.6 test data statistics:
Use SPSS statistical software process body weight result and carry out the comparative analysis of administration group and control group.Add up in accordance with the following methods: Kolmogorov-Smirnov method should be adopted to carry out Normal distribution test, Levene median method carries out homogeneity test of variance, if P > 0.05, carry out one-way analysis of variance (One-Way ANOVA) method, if normal state and homogeneity test of variance failure (P≤0.05), so need to carry out nonparametric Mann-Whitney inspection.
1.7 results judge
Result judges: test group of animals blood pressure is starkly lower than control group, and difference has conspicuousness, and on test group of animals heart rate without impact, can judge that auxiliary function for lowering blood pressure results of animal is positive.
2. result
Animal ordinary circumstance is observed each group and is showed no exception.
Table 9 kinetic energy water on the impact of normal SD rat blood pressure systolic pressure (SBP, mmHg,
n=10)
From table 9, Figure 15, administration first week, second week, the 3rd week, 4th week, compare with control group, kinetic energy water is low, high dose group rat systolic pressure compares with control group and be showed no significant difference, absolute value change little (p>0.05).Compare with control group, chiang ya wan group rat systolic pressure has no significant difference, absolute value absolute value change little (p>0.05).
Table 10 kinetic energy water on the impact of normal SD rat blood pressure diastolic pressure (DBP, mmHg,
n=10)
From table 10, Figure 16, administration first week, second week, the 3rd week, 4th week, compare with control group, kinetic energy water is low, high dose group rat diastolic pressure compares with control group and be showed no significant difference, absolute value change little (p>0.05).Compare with control group, chiang ya wan group rat diastolic pressure has no significant difference, absolute value absolute value change little (p>0.05).
Table 11 kinetic energy water on the impact of normal SD rat blood pressure mean pressure (DBP, mmHg,
n=10)
From table 11, Figure 17, administration first week, second week, the 3rd week, 4th week, compare with control group, kinetic energy water be low, the mean pressure of high dose group rat has no significant difference, absolute value change little (p>0.05).Compare with control group, the mean pressure of chiang ya wan group rat has no significant difference, absolute value absolute value change little (p>0.05).
Table 12 kinetic energy water on the impact of normal SD rat heart rate (HR, secondary/min,
n=10)
From table 12, Figure 18, administration first week, second week, the 3rd week, 4th week, compare with control group, kinetic energy water be low, high dose group rat heart rate has no significant difference, absolute value change little (p>0.05).Compare with control group, chiang ya wan group rat heart rate has no significant difference, absolute value absolute value change little (p>0.05).
Table 13, kinetic energy water on the impact of normal SD rat body weight (g,
n=10)
Note: compare with control group, * p<0.05; * p<0.01
From table 13, Figure 19, administration the 3rd week, 4th week, compare with control group, and kinetic energy water low dose group rat body weight increases to some extent, compares have significant difference (the 3rd week: 254 ± 9*, vs 241 ± 14 with control group; 4th week: 269 ± 6**, vs 252 ± 17, g, * p<0.05, * * p<0.01).
3. brief summary
Comprehensive the above results, under this experiment condition, drinks multipole fine motion energy drinking water of the present invention continuously 32 days, has no obvious impact to normal rat blood pressure.
Claims (10)
1. multipole fine motion energy drinking water is for the preparation of the purposes in hypotensive beverage, health products or medicine.
2. purposes according to claim 1, it is characterized in that, described multipole fine motion energy drinking water adopts the former water of the contactless Drinking Water of electromagnetic wave of basic, normal, high three kinds of different frequencies to be prepared from, wherein, the frequency range of low-frequency electromagnetic wave is 30-100kHz, intermediate frequency electromagnetic wave frequency scope is 550-720kHz, and the frequency range of frequency electromagnetic waves is 300-725MHz.
3. purposes according to claim 1 and 2, is characterized in that, described Raw Drinking Water is ordinary tap water or various mineral water or pure water, such as Evian natural mineral water, Glacier in Tibet mineral water, NongFuShanQuan, Wahaha etc.
4. purposes according to any one of claim 1 to 3, is characterized in that, the frequency range of described low-frequency electromagnetic wave is 45-75kHz;
Preferably, described intermediate frequency electromagnetic wave frequency scope is 600-720kHz;
Preferably, the frequency range of described frequency electromagnetic waves is 300-425MHz.
5. purposes according to any one of claim 1 to 4, is characterized in that, described low-frequency electromagnetic wave and medium frequency electric magnetic wave are sine wave, square wave, sharp wave, sawtooth waveforms or trapezoidal wave;
Preferably, described low-frequency electromagnetic wave is identical with intermediate frequency electromagnetic waveform or different;
More preferably, described low-frequency electromagnetic wave is preferably identical with intermediate frequency electromagnetic waveform.
6. purposes according to any one of claim 1 to 5, it is characterized in that, described low-frequency electromagnetic wave is consistent with intermediate frequency electromagnetic direction of wave travel.
7. purposes according to any one of claim 1 to 6, described frequency electromagnetic waves is triangular wave, and vertical with intermediate frequency electromagnetic direction of wave travel with described low-frequency electromagnetic wave.
8. purposes according to any one of claim 1 to 7, it is characterized in that, when adopting the contactless Drinking Water original sub-block of the electromagnetic wave of basic, normal, high three kinds of different frequencies, first use low-frequency electromagnetic wave and frequency electromagnetic waves to process simultaneously, and then use medium frequency electric magnetic wave and frequency electromagnetic waves to process simultaneously;
Preferably, the time using low-frequency electromagnetic wave and frequency electromagnetic waves simultaneously to process is 10-30 minute, is preferably 10-20 minute;
More preferably, the time using medium frequency electric magnetic wave and frequency electromagnetic waves simultaneously to process is 10-30 minute, is preferably 10-20 minute.
9. purposes according to any one of claim 1 to 8, it is characterized in that, compared with Raw Drinking Water, the ultraviolet absorption peak of described multipole fine motion energy drinking water is to shortwave direction skew 25nm-40nm, preferably to shortwave direction skew 28nm-30nm, most preferably to shortwave direction skew 30nm or 28nm.
10. purposes according to any one of claim 1 to 9, is characterized in that, described beverage is drinks, may be used for hypotensive;
Preferably, described health products or medicine may be used for hypotensive.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510125016.XA CN104757673A (en) | 2015-03-20 | 2015-03-20 | Application of multipolar micro kinetic energy drinking water in preparation of beverage, health product or medicine for lowering blood pressure |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510125016.XA CN104757673A (en) | 2015-03-20 | 2015-03-20 | Application of multipolar micro kinetic energy drinking water in preparation of beverage, health product or medicine for lowering blood pressure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104757673A true CN104757673A (en) | 2015-07-08 |
Family
ID=53640049
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510125016.XA Pending CN104757673A (en) | 2015-03-20 | 2015-03-20 | Application of multipolar micro kinetic energy drinking water in preparation of beverage, health product or medicine for lowering blood pressure |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104757673A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016149879A1 (en) * | 2015-03-20 | 2016-09-29 | 欢乐海（北京）水业科技有限公司 | Uses of multipolar microkinetic drinking water in preparing drink, healthcare product or medicament used for combating fatigue |
| WO2016149885A1 (en) * | 2015-03-20 | 2016-09-29 | 欢乐海（北京）水业科技有限公司 | Uses of multipolar microkinetic drinking water in preparing drink, healthcare product or medicament for reducing blood urea |
| WO2016149872A1 (en) * | 2015-03-20 | 2016-09-29 | 欢乐海（北京）水业科技有限公司 | Multipolar microkinetic drinking water, preparation method for same, and uses thereof |
| WO2016149883A1 (en) * | 2015-03-20 | 2016-09-29 | 欢乐海（北京）水业科技有限公司 | Uses of multipolar microkinetic drinking water in preparing drink, healthcare or medicament used for reducing blood pressure |
| WO2016149886A1 (en) * | 2015-03-20 | 2016-09-29 | 欢乐海（北京）水业科技有限公司 | Uses of multipolar microkinetic drinking water in preparing drink, healthcare product or medicament for use in reducing blood urea |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101466643A (en) * | 2006-05-29 | 2009-06-24 | 株式会社志贺机能水研究所 | Electromagnetic field treatment method and electromagnetic field treatment equipment of water |
| CN103058430A (en) * | 2012-12-18 | 2013-04-24 | 华南理工大学 | Preparation method of high energy water with small molecules |
| CN104402153A (en) * | 2014-11-28 | 2015-03-11 | 华南理工大学 | Method for preparing stable small-molecular water by utilizing microwave-ultrasonic wave |
-
2015
- 2015-03-20 CN CN201510125016.XA patent/CN104757673A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101466643A (en) * | 2006-05-29 | 2009-06-24 | 株式会社志贺机能水研究所 | Electromagnetic field treatment method and electromagnetic field treatment equipment of water |
| CN103058430A (en) * | 2012-12-18 | 2013-04-24 | 华南理工大学 | Preparation method of high energy water with small molecules |
| CN104402153A (en) * | 2014-11-28 | 2015-03-11 | 华南理工大学 | Method for preparing stable small-molecular water by utilizing microwave-ultrasonic wave |
Non-Patent Citations (2)
| Title |
|---|
| 张建平等: "水分子团簇结构的改变及其生物效应", 《化学通报》 * |
| 王建华等: "微波对水分子团簇结构影响的探究", 《菏泽学院学报》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016149879A1 (en) * | 2015-03-20 | 2016-09-29 | 欢乐海（北京）水业科技有限公司 | Uses of multipolar microkinetic drinking water in preparing drink, healthcare product or medicament used for combating fatigue |
| WO2016149885A1 (en) * | 2015-03-20 | 2016-09-29 | 欢乐海（北京）水业科技有限公司 | Uses of multipolar microkinetic drinking water in preparing drink, healthcare product or medicament for reducing blood urea |
| WO2016149872A1 (en) * | 2015-03-20 | 2016-09-29 | 欢乐海（北京）水业科技有限公司 | Multipolar microkinetic drinking water, preparation method for same, and uses thereof |
| WO2016149883A1 (en) * | 2015-03-20 | 2016-09-29 | 欢乐海（北京）水业科技有限公司 | Uses of multipolar microkinetic drinking water in preparing drink, healthcare or medicament used for reducing blood pressure |
| WO2016149886A1 (en) * | 2015-03-20 | 2016-09-29 | 欢乐海（北京）水业科技有限公司 | Uses of multipolar microkinetic drinking water in preparing drink, healthcare product or medicament for use in reducing blood urea |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104757673A (en) | Application of multipolar micro kinetic energy drinking water in preparation of beverage, health product or medicine for lowering blood pressure | |
| Szymańska et al. | Multifunctional tannic acid/silver nanoparticle-based mucoadhesive hydrogel for improved local treatment of HSV infection: In vitro and in vivo studies | |
| Kang et al. | A near-infrared fluorescent probe for ratiometric imaging peroxynitrite in Parkinson's disease model | |
| CN104757674A (en) | Application of multi-level micro-kinetic-energy drinking water to preparation of beverage, health product or medicament for fatigue resistance | |
| CN104757675A (en) | Application of multi-level micro-kinetic-energy drinking water to preparation of beverage, health product or medicament for lowering blood uric acid | |
| CN104757672A (en) | Application of multipolar micro kinetic energy drinking water in preparation of beverage, health product or medicine for reducing fat | |
| Wei et al. | Accelerating the clearance of mutant huntingtin protein aggregates through autophagy induction by europium hydroxide nanorods | |
| CN104720058A (en) | Application of multi-pole micro-kinetic-energy drinking water in preparation of beverage, health product or drug for relaxing bowels | |
| CN104784207A (en) | Use of multipolar micro-kinetic drinking water in preparing beverages, health-care products or medicines for reducing blood urea | |
| Kihara et al. | Effect of composition, morphology and size of nanozeolite on its in vitro cytotoxicity | |
| CN104803440B (en) | A kind of multipole fine motion energy drinking water and its production and use | |
| CN105566317A (en) | Compound and preparation method thereof | |
| CN107619085A (en) | A kind of preparation facilities and method of small molecule energy water | |
| Jiang et al. | Comprehensive evaluation of the nephrotoxicity of carbon quantum dots: Effects of the surface charge | |
| CN103175929B (en) | The HPLC-MS-MS detection method of residual chloromycetin in functional food | |
| CN106282112A (en) | The method for building up of the mouse monokaryon macrophage system oxidative stress model of hydrogen peroxide-induced | |
| CN105319332A (en) | Quality evaluation method of blood-fat-reducing traditional Chinese medicines on the basis of bio-titer | |
| CN204964532U (en) | Full -automatic smear analytical equipment | |
| Liu et al. | Spectroscopic investigation on protein damage by ciprofloxacin under ultrasonic irradiation | |
| WO2016149872A1 (en) | Multipolar microkinetic drinking water, preparation method for same, and uses thereof | |
| CN106153664B (en) | A kind of method, test solution and method for preparing test solution for detecting marine polysaccharide antioxidation | |
| WO2016149883A1 (en) | Uses of multipolar microkinetic drinking water in preparing drink, healthcare or medicament used for reducing blood pressure | |
| AU2015101913A4 (en) | Uses of electromagnetic wave treated drinking water in preparing drink, healthcare product or medicament used for loosening stool | |
| AU2015101911A4 (en) | Uses of multipolar microkinetic drinking water in preparing drink, healthcare product or medicament used for weight reduction | |
| WO2016149886A1 (en) | Uses of multipolar microkinetic drinking water in preparing drink, healthcare product or medicament for use in reducing blood urea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150708 |
|
| RJ01 | Rejection of invention patent application after publication |